A Simple Formula to Estimate Parathyroid Weight on 4D-CT, Predict Pathologic Weight, and Diagnose Parathyroid Adenoma in Patients with Primary Hyperparathyroidism

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2020 Aug 21

PMID 32816774

Citations 7

Authors

R Yeh

Y-K D Tay

L Dercle

L Bandeira

M R Parekh

J P Bilezikian

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Parathyroid gland weight is a clinically relevant parameter used to diagnose parathyroid adenomas intraoperatively. We evaluated the accuracy of a formula to estimate parathyroid weight on preoperative 4D-CT.

Materials And Methods: A single-institution retrospective study was performed in patients with primary hyperparathyroidism who underwent 4D-CT between January 2013 and December 2014 with subsequent parathyroidectomy and surgical cure. All patients had correct localization of a solitary parathyroid adenoma. The longest 3 dimensions of all identified parathyroid glands were measured on CT, and weight was estimated using the formula: weight (mg) = 1 mg/mm × Length (mm) × Width (mm) × Height (mm) × π/6. We correlated weight with pathology specimen weight (weight). Using receiver operating characteristic analysis, we estimated the performance of weight to discriminate a parathyroid adenoma from normal glands on 4D-CT and determined the optimal threshold based on the Youden index.

Results: One hundred sixteen patients (85 women, 31 men) were evaluated. Weight was shown to be strongly correlated with weight as demonstrated by Spearman ρ = 0.73 ( < .01), concordance correlation coefficient = 0.92 (95% CI, 0.89-0.94), and Cronbach α = 0.96. The performance of weight for the diagnosis of parathyroid adenoma was excellent, with an area under the curve of 0.955 (95% CI, 0.925-0.985; < .001). Based on the Youden index, the optimal threshold was >50 mg, with a sensitivity of 96.7% and a specificity of 95.7%.

Conclusions: Radiologists can accurately estimate parathyroid adenoma weight on 4D-CT. This metric is highly correlated with pathologic weight, and a threshold cutoff of >50 mg can be used to distinguish parathyroid adenoma from normal glands.

Citing Articles

Machine learning-derived clinical decision algorithm for the diagnosis of hyperfunctioning parathyroid glands in patients with primary hyperparathyroidism.

Yeh R, Kuo J, Huang B, Shobeiri P, Lee J, Tay Y Eur Radiol. 2024; 35(3):1325-1336.

PMID: 39476058 DOI: 10.1007/s00330-024-11159-8.

Endocrine gland size is proportional to its target tissue size.

Raz M, Milo T, Glass D, Mayo A, Alon U iScience. 2024; 27(9):110625.

PMID: 39224518 PMC: 11367476. DOI: 10.1016/j.isci.2024.110625.

Ultrasound characteristics of normal parathyroid glands and analysis of the factors affecting their display.

Wu C, Zhu B, Kang S, Wang S, Liu Y, Mei X BMC Med Imaging. 2024; 24(1):42.

PMID: 38350842 PMC: 10863184. DOI: 10.1186/s12880-024-01214-7.

Neck Reoperation for Recurrent or Persistent Renal Hyperparathyroidism.

Chang L, Liu S, Liang T World J Surg. 2023; 47(11):2784-2791.

PMID: 37714965 DOI: 10.1007/s00268-023-07172-5.

Pan-Cancer Analysis Reveals the Signature of TMC Family of Genes as a Promising Biomarker for Prognosis and Immunotherapeutic Response.

Song J, Tang Y, Luo X, Shi X, Song F, Ran L Front Immunol. 2021; 12:715508.

PMID: 34899684 PMC: 8660091. DOI: 10.3389/fimmu.2021.715508.

References

Day K, Elsayed M, Beland M, Monchik J . The utility of 4-dimensional computed tomography for preoperative localization of primary hyperparathyroidism in patients not localized by sestamibi or ultrasonography. Surgery. 2015; 157(3):534-9. DOI: 10.1016/j.surg.2014.11.010. View

Bilezikian J, Khan A, Potts Jr J . Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009; 94(2):335-9. PMC: 3214274. DOI: 10.1210/jc.2008-1763. View

Nichols K, Tronco G, Palestro C . Influence of Multigland Parathyroid Disease on 99mTc-Sestamibi SPECT/CT. Clin Nucl Med. 2016; 41(4):282-8. DOI: 10.1097/RLU.0000000000001115. View

Grimelius L, Bondeson L . Histopathological diagnosis of parathyroid diseases. Pathol Res Pract. 1995; 191(4):353-65. DOI: 10.1016/S0344-0338(11)80889-7. View

Lampen-Sachar K, Zhao B, Zheng J, Moskowitz C, Schwartz L, Zakowski M . Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas. Lung Cancer. 2011; 75(3):332-5. PMC: 4441034. DOI: 10.1016/j.lungcan.2011.08.001. View

Galvin L, Oldan J, Bahl M, Eastwood J, Sosa J, Hoang J . Parathyroid 4D CT and Scintigraphy: What Factors Contribute to Missed Parathyroid Lesions?. Otolaryngol Head Neck Surg. 2016; 154(5):847-53. DOI: 10.1177/0194599816630711. View

Yao K, Singer F, Roth S, Sassoon A, Ye C, Giuliano A . Weight of normal parathyroid glands in patients with parathyroid adenomas. J Clin Endocrinol Metab. 2004; 89(7):3208-13. DOI: 10.1210/jc.2003-031184. View

Starker L, Mahajan A, Bjorklund P, Sze G, Udelsman R, Carling T . 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol. 2010; 18(6):1723-8. DOI: 10.1245/s10434-010-1507-0. View

Tann M, Sopov V, Croitoru S, Nativ O, Moskovitz B, Bar-Meir E . How accurate is helical CT volumetric assessment in renal tumors?. Eur Radiol. 2001; 11(8):1435-8. DOI: 10.1007/s003300000789. View

10.

Roth S, Gallagher M . The rapid identification of "normal" parathyroid glands by the presence of intracellular fat. Am J Pathol. 1976; 84(3):521-8. PMC: 2032533. View

11.

Yeh R, Tay Y, Tabacco G, Dercle L, Kuo J, Bandeira L . Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism. Radiology. 2019; 291(2):469-476. PMC: 7440755. DOI: 10.1148/radiol.2019182122. View

12.

Rodgers S, Hunter G, Hamberg L, Schellingerhout D, Doherty D, Ayers G . Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006; 140(6):932-40. DOI: 10.1016/j.surg.2006.07.028. View

13.

Akerstrom G, Grimelius L, Johansson H, Lundqvist H, Pertoft H, Bergstrom R . The parenchymal cell mass in normal human parathyroid glands. Acta Pathol Microbiol Scand A. 1981; 89(5):367-75. DOI: 10.1111/j.1699-0463.1981.tb00234.x. View

14.

Tay Y, Yeh R, Kuo J, McManus C, Lee J, Bilezikian J . Pre-operative localization of abnormal parathyroid tissue by Tc-sestamibi in primary hyperparathyroidism using four-quadrant site analysis: an evaluation of the predictive value of vitamin D deficiency. Endocrine. 2018; 60(1):36-45. DOI: 10.1007/s12020-018-1528-1. View

15.

Wang C, RIEDER S . A density test for the intraoperative differentiation of parathyroid hyperplasia from neoplasia. Ann Surg. 1978; 187(1):63-7. PMC: 1396413. DOI: 10.1097/00000658-197801000-00012. View

16.

Hoang J, Sung W, Bahl M, Phillips C . How to perform parathyroid 4D CT: tips and traps for technique and interpretation. Radiology. 2013; 270(1):15-24. DOI: 10.1148/radiol.13122661. View

17.

Stucken E, Kutler D, Moquete R, Kazam E, Kuhel W . Localization of small parathyroid adenomas using modified 4-dimensional computed tomography/ultrasound. Otolaryngol Head Neck Surg. 2011; 146(1):33-9. DOI: 10.1177/0194599811427243. View

18.

Kunstman J, Kirsch J, Mahajan A, Udelsman R . Clinical review: Parathyroid localization and implications for clinical management. J Clin Endocrinol Metab. 2013; 98(3):902-12. DOI: 10.1210/jc.2012-3168. View

19.

Richards M, Thompson G, Farley D, Grant C . An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg. 2011; 146(3):280-5. DOI: 10.1001/archsurg.2011.5. View

20.

Suh Y, Choi J, Kim S, Chun I, Yun T, Lee K . Comparison of 4D CT, ultrasonography, and 99mTc sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism. Otolaryngol Head Neck Surg. 2014; 152(3):438-43. DOI: 10.1177/0194599814562195. View